Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems
- The Company achieves significant milestone with initial revenues generated from FDA-cleared life support technology deployed in a leading U.S. healthcare facility; additional systems currently planned for second hospital facility The Company achieves significant milestone with initial revenues generated from FDA-cleared life support technology deployed in a leading U.S. healthcare facility; additional systems currently planned for second hospital facility
- 04/15/2025
|
Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital
- Inspira's innovative FDA-cleared INSPIRA™ ART100 system was successfully deployed at premier U.S. hospital, with systems in place for clinical use RA'ANANA, Israel , March 25, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that it has successfully completed the installation, training program and operational readiness for its INSPIRA ART100 system for cardiopulmonary bypass procedures at one of New York's premier hospitals.
- 03/25/2025
|
Market Alert: Inspira Technologies' Respiratory Tech Could Transform $19B Ventilator Market Amid Major Wave of Multi Billion Dollar Medtech Acquisitions
- NEW YORK--(BUSINESS WIRE)--Market News Alerts Reports: Inspira Technologies (NASDAQ: IINN)* is reported beginning deployment of its FDA-cleared INSPIRA ART100 system at a leading New York cardiothoracic program ranked among the top 15% nationally, marking a significant commercialization milestone in a sector experiencing unprecedented M&A activity. The medtech industry saw multiple billion-dollar acquisitions in 2024, including Johnson & Johnson's $13.1 billion acquisition of Shockwave.
- 03/24/2025
|
Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego
- Leading perfusion professionals to experience Inspira's FDA-cleared cardiopulmonary bypass INSPIRA™ ART100 technology at premier industry event RA'ANANA, Israel , March 19, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira," "Inspira Technologies" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that its U.S. Food and Drug Administration-cleared life-support system, the INSPIRA™ ART100, will be showcased at the American Society of Extracorporeal Technology (AmSECT) 63rd International Conference, taking place March 19-23, 2025, at the Loews Coronado Bay Resort in San Diego, California, by their distributor Glo-Med Networks Inc ("Glo-Med").
- 03/19/2025
|
PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market
- NEW YORK--(BUSINESS WIRE)---- $IINN #biotech--PESG Research releases an update following Inspira Technologies' (NASDAQ: IINN)* recent strategic developments and clinical achievements: Inspira has emerged as a potential disruptive force in respiratory care with its integrated technology approach. The company's recent clinical studies demonstrating 96% accuracy for its AI-powered HYLA blood sensor represent a significant technological validation as it targets multiple high-value healthcare segments. Inspira's integ.
- 03/18/2025
|
Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care
- Letter from the CEO / March 14, 2025 RA'ANANA, Israel , March 14, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. ("Inspira," "Inspira Technologies" or the "Company") (Nasdaq: IINN), a pioneering force in the evolution of respiratory support and real-time blood-monitoring technologies, is pleased to share this update to shareholders from its Chief Executive Officer, Director, and Co-founder, Mr.
- 03/14/2025
|
Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
- RA'ANANA, Israel , March 13, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that on March 10, 2025, the Company received a written notice (the "Notice") from the Nasdaq Stock Market LLC indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the Company's closing bid price for its ordinary shares, or Ordinary Shares, was below $1.00 per share for the last 30 consecutive business days.
- 03/13/2025
|
Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates
- Significant progress in HYLA blood sensor and INSPIRA ART core technologies RA'ANANA, Israel , March 11, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced its financial results for the full year ended December 31, 2024, and provided a corporate update.
- 03/11/2025
|
PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations
- NEW YORK--(BUSINESS WIRE)---- $IINN #biotech--PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies* (NASDAQ: IINN) has reported exceptional clinical study outcomes for its HYLA blood sensor, with 96% accuracy achieved in a key parameter compared to traditional blood analyzers. This milestone achievement validates the company's AI-powered continuous blood monitoring technology and accelerates its path toward commercial deployment in multiple healthcare setting.
- 03/05/2025
|
Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy
- Inspira's AI-powered continuous blood monitoring technology demonstrated a high degree of accuracy in a key parameter, targeting multiple multi-billion-dollar market segments; Company plans to advance with ongoing clinical study following this success; FDA submission planned for H2 2025 RA'ANANA, Israel , March 4, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced positive results from the clinical study of its AI-powered HYLA™ blood sensor.
- 03/04/2025
|
Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections
- The ex-vivo testing demonstrated significant bacterial reduction for the innovative IV dressing technology aimed at preventing bloodstream infections in critical patients RA'ANANA, Israel , Feb. 11, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in breakthrough life-support technology, today announced positive initial results from its previously reported collaboration with Ennocure MedTech Ltd.
- 02/11/2025
|
Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor
- Inspira Technologies develops its innovative AI-powered HYLA technology with advanced blood testing capability, enabling continuous monitoring of tissue oxygenation and early hypoxia detection; Company expects to release preliminary clinical results for the sensor in the near future RA'ANANA, Israel , Feb. 5, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in breakthrough life-support technology, today announced the integration of a next-generation oxygenation indicator into its AI-powered HYLA™ blood sensor technology, designed to enable the rapid detection of critical oxygen-related conditions without the need for intermittent blood draws.
- 02/05/2025
|
Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support
- RA'ANANA, Israel , Jan. 27, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira," or the "Company"), a leader in innovative medical technology, has announced the addition of new support features to the INSPIRA™ ART100, a system cleared by the U.S. Food and Drug Administration.
- 01/27/2025
|
Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital
- RA'ANANA, Israel , Jan. 22, 2025 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW), ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking respiratory support technology company, announced that its INSPIRA™ ART100 systems have been delivered to Glo-Med Networks Inc. ("Glo-Med") and are now being prepared for their first planned deployment at a leading U.S. hospital.
- 01/22/2025
|
Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors
- RA'ANANA, Israel , Jan. 21, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) ("Inspira" or the "Company"), a leader in life-support technology innovation, has announced the appointment of Mr.
- 01/21/2025
|
Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line
- RA'ANANA, ISRAEL , Jan. 17, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company"), a leader in life-support technology innovation, has announced that the Company is establishing a dedicated production line for a crucial component of its innovative respiratory support system, in collaboration with Zriha Medical Ltd ("Zriha Medical"), a leading international manufacturer specializing in medical device production.
- 01/17/2025
|
Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology
- The technology has the potential to provide life-saving support for the approximately 20 million ICU patients with respiratory failure annually RA'ANANA, Israel , Jan. 14, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company"), a leader in life-support technology innovation, is proud to announce the development of a modular configuration for its groundbreaking VORTX blood oxygenation delivery technology.
- 01/14/2025
|
Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China
- RA'ANANA, Israel , Jan. 10, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) ("Inspira" or the "Company"), a leader in life-support technology innovation, announced today that it is preparing for a potential production ramp-up of its INSPIRA™ ART100 device.
- 01/10/2025
|
Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai
- Visitors at Glo-Med Network Inc's booth can explore Inspira's cutting-edge respiratory solutions, with the FDA-cleared INSPIRA™ ART100, showcasing the future of respiratory care RA'ANANA, Israel , Jan. 7, 2025 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW), ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking respiratory support technology company, is pleased to announce that the INSPIRA™ ART100, a cardiopulmonary bypass system will be showcased at Arab Health 2025, one of the largest healthcare exhibitions in the Middle East, expected to have over 3,800 exhibitors and over 180 visiting countries.
- 01/07/2025
|
Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company
- RA'ANANA, Israel , Dec. 27, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN), (NASDAQ: IINNW), ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking respiratory support technology company, a pioneer in life-support technology, today announced the pricing of a private placement offering consisting of the issuance and sale of 4,608,715 ordinary shares, no par value per share (or pre-funded warrants in lieu thereof) and ordinary warrants to purchase up to 4,608,715 ordinary shares, at a combined purchase price of $0.70.
- 12/27/2024
|
Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment
- RA'ANANA, Israel , Dec. 16, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN, IINNW), ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking respiratory support technology company, announced the delivery of INSPIRA™ ART100 systems to its U.S. distributor, Glo-Med Networks Inc ("Glo-Med").
- 12/16/2024
|
Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions
- RA'ANANA, Israel , Dec. 10, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN, IINNW), ("Inspira Technologies" or the "Company"), a groundbreaking life support technology company, revealed the expansion of its HYLA blood sensor technology ("HYLA") into an immediate personalized Blood Lab Test, aimed at performing real-time patient blood work for the rapid detection in minutes of the potential development of an underlying life-threatening medical condition.
- 12/10/2024
|
Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios
- RA'ANANA, Israel , Dec. 4, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN), (Nasdaq: IINNW) ("Inspira Technologies", "Inspira" or the "Company"), a groundbreaking life support technology company, entered into a strategic collaboration with Westchester Medical Center in Valhalla, New York.
- 12/04/2024
|
Join Inspira™ Technologies' Live Investor Webinar and Q&A Session on November 11
- RA'ANANA, Israel, Nov. 8, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN), ("Inspira Technologies" or the "Company"), an innovative medical technology company in the life support and respiratory treatment arena, is pleased to invite investors to a webinar on November 11, 2024, at 4:15 p.m.
- 11/08/2024
|
Inspira™ Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA™ ART100
- The Company has signed a distribution agreement that assigns to Glo-Med the role of Inspira's primary distributor and customer support center in the U.S. RA'ANANA, Israel , Oct. 24, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira Technologies", "Inspira" or the "Company"), a groundbreaking life support technology company, is pleased to announce that it has entered into an agreement with Glo-Med Networks Inc ("Glo-Med"), which will serve as Inspira's primary distributor in the United States.
- 10/24/2024
|
Inspira™ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism
- RA'ANANA, Israel , Oct. 9, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) ("Inspira Technologies", "Inspira" or the "Company"), a groundbreaking respiratory support technology company, is pleased to announce the development of a new disposable kit for the perfusion market.
- 10/09/2024
|
Inspira Stock to Gain From its Appearance at Annual ELSO Conference
- At the 34th annual ELSO conference in Detroit, IINN will present its FDA-cleared latest and future technology, the INSPIRA ART100 system.
- 09/25/2024
|
Inspira™ Launches INSPIRA™ ART100 at the World's Largest Extracorporeal Life Support Conference
- RA'ANANA, Israel , Sept. 24, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N.
- 09/24/2024
|
IINN Stock Gains on Second US Patent Approval for VORTX System
- Inspira secures a second U.S. Patent approval for the VORTX orbiting blood oxygenation delivery system.
- 09/16/2024
|
Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System
- To date, a combined total of 32 claims have been deemed novel for the core technology of the INSPIRA™ ART device Targeting treatment for 20 million ICU patients with respiratory failure annually, with many relying on mechanical ventilators, in a $19 billion industry RA'ANANA, Israel , Sept. 13, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N.
- 09/13/2024
|
Favorable Clinical Results for HYLA Sensor Might Boost Inspira Stock
- IINN plans to report clinical results for its new HYLA blood sensor in open-heart surgery patients in the fourth quarter of 2024.
- 09/02/2024
|
Inspira™ to Publish HYLA™ Clinical Results in Fourth Quarter 2024
- The clip-on HYLA™ blood sensor, designed to alert physicians of immediate signs of changes in a patient's clinical condition without the need for intermittent actual blood samples, targets a potential $2.5 billion Point of Care testing and Arterial Blood Gas (ABG) analyzer market. RA'ANANA, Israel , Aug. 28, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N.
- 08/28/2024
|
INSPIRA (IINN) CART Gets FDA Listing, to Enhance Healthcare
- Inspira (IINN) announces FDA listing of its INSPIRA CART, designed for use with the ART100 system, enhancing healthcare delivery during cardiopulmonary bypass.
- 08/23/2024
|
Inspira™ Technologies Announces FDA Listing and Market Readiness of New Product
- RA'ANANA, Israel , Aug. 22, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) ("Inspira" or the "Company"), a leader in life-support technology innovation, today announces the U.S. Food and Drug Administration ("FDA") listing of its medical cart (INSPIRA™ CART) which has been custom designed for use with the INSPIRA™ ART100 system.
- 08/22/2024
|
Inspira™ Approached by Large Medical Company to Evaluate Operation of their Key Product with INSPIRA™ ART100 - Results Exceed 100% at Maximum Flow
- RA'ANANA, Israel , Aug. 13, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) ("Inspira," "Inspira Technologies," or the "Company"), a trailblazer in life-support technology, today announced that it was approached by a leading medical technology company in the industry, to evaluate the operation of its proprietary key product in combination with the INSPIRA™ ART100 system.
- 08/13/2024
|
Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest
- Inspira's innovation targets life-saving intervention for patients with cardiac arrest, of which there are approximately 550,000 annual cardiac arrest events in the U.S., including 350,000 outside hospitals, where the survival rate is less than 10%. The INSPIRA Cardi-ART provides the Company a new market opportunity to target the $39.8 billion global cardiac arrest market.
- 07/30/2024
|
Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System
- Approval follows the FDA clearance announced on May 28, 2024 RA'ANANA, Israel , July 11, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, is excited to announce the receipt of the Israeli Ministry of Health's medical devices and accessories ("AMAR") approval for the INSPIRA™ ART100, an Extra-Corporeal Membrane Oxygenation and Cardiopulmonary Bypass system.
- 07/11/2024
|
Inspira (IINN) Unveils Business Targets for 2024-25
- Inspira (IINN) discloses business goals for 2024-25 with the rapid promotion of INSPIRA ART100 and the development of INSPIRA ART (Gen 2).
- 06/21/2024
|
Inspira™ Announces Business Plan Targets
- Company to aggressively promote INSPIRA™ ART100 in the U.S. and additional markets following FDA clearance, as well as accelerate plans for ground-breaking INSPIRA™ ART (Gen2) RA'ANANA, Israel , June 20, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN), (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, announced today that the Company's President and co-founder, Mr.
- 06/20/2024
|
Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel
- RA'ANANA, Israel , June 17, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, is proud to announce today that the Company will present at the annual iECOs Conference in Herzliya, Israel on June 18th, 2024.
- 06/17/2024
|
Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.
- First units expected to be shipped in Q4 2024. The Purchase Order follows the recent FDA Clearance of the INSPIRA™ ART100.
- 06/13/2024
|
Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector
- The event is an opportunity to present and demonstrate new products and technologies to potential customers and strategic partners RA'ANANA, Israel , June 5, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, is proud to announce plans to exhibit the INSPIRA™ ART100 System, recently cleared by the U.S. Food and Drug Administration ("FDA"), at the Extracorporeal Life Support Organization (ELSO) conference in Detroit, Michigan between September 29 to October 1, 2024.
- 06/05/2024
|
Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments
- RA'ANANA, Israel , May 30, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira") a breakthrough medical technology company, announced today that Company President, Director, and co-founder, Mr.
- 05/30/2024
|
Inspira Technologies' (IINN) ART100 Gets FDA 510(k) Grant
- Inspira Technologies' (IINN) ART100 recent approval highlights the company's innovative advancements in medical technology.
- 05/29/2024
|
INSPIRA™ ART100 Receives FDA 510(k) Clearance
- RA'ANANA, Israel , May 28, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company", "Inspira", or "Inspira Technologies"), a breakthrough medical technology company, today announced that it has received notification of 510(k) class II clearance from the U.S. Food and Drug Administration (FDA) for its INSPIRA™ ART100, a Cardiopulmonary Bypass System.
- 05/28/2024
|
Inspira™ Announces Start of Production of the INSPIRA™ ART100
- RA'ANANA, Israel , May 2, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, announced the start of production of the INSPIRA ART100 medical device.
- 05/02/2024
|
Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
- RA'ANANA, Israel , April 25, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, announced that it has received the Canadian Standards Association (CSA) Certification of Compliance to U.S. standards for the INSPIRA ART100 device.
- 04/25/2024
|
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
- RA'ANANA, Israel , April 16, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, is proud to announce the signing of a collaboration term sheet (the "Term Sheet") with the Beilinson Hospital in Israel for the evaluation of its proprietary INSPIRA ART100 device (the "Device") in organ transplant procedures.
- 04/16/2024
|
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
- RA'ANANA, Israel , April 10, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, together with Ennocure MedTech Ltd.
- 04/10/2024
|
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
- RA'ANANA, Israel , April 3, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, is delighted to announce the commencement of a program to explore the applicable use of the INSPIRA™ ART100 Device for an artificial womb for neonates in need of vital respiratory support.
- 04/03/2024
|
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
- RA'ANANA, Israel , April 1, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira"), today announced a strategic investment by leading investor, Mr.
- 04/01/2024
|
Inspira™ Technologies Reports Full Year 2023 Financial Results
- FDA Submission for approval of INSPIRA™ ART100 95% Accuracy Results for HYLA™ Blood Sensor Compared to Standard Blood Gas Analyzers Granted U.S. Patent for INSPIRA™ ART Medical Device RA'ANANA, Israel , March 25, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, today announced its financial results for the year ended December 31, 2023.
- 03/25/2024
|
Inspira Technologies (IINN) Strives to Get AMAR Nod for ART100
- The AMAR submission is a strategic move by Inspira Technologies (IINN), positioning it to target global markets with its innovative Augmented Respiration Technology (INSPIRA ART).
- 03/19/2024
|
Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets
- RA'ANANA, Israel , March 18, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, is excited to announce the AMAR submission for approval of the INSPIRA™ ART100, marking a significant milestone in Inspira's venture into new markets.
- 03/18/2024
|
Inspira Technologies (IINN) Releases Favorable Data on VORTX
- Inspira Technologies' (IINN) proprietary orbiting oxygenation technology eliminates the need for membrane fibers, thereby reducing pressure differentials and high shear stress.
- 03/14/2024
|
Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
- An unprecedented achievement of a zero pressure gradient measured when using the VORTX™ device, directly correlating with a decrease in markers of blood damage. The performance of the VORTX™, tested according to a regulatory guideline, was found to meet 100% of blood oxygenation requirements at various blood flow rates.
- 03/12/2024
|
Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days
- The major milestone refers to Inspira's proprietary technology to oxygenate blood for the INSPIRA™ ART (Gen 2). This patented tech is considered by Inspira to be a game-changer and also aims to replace technologies used today by current medical device companies.
- 03/04/2024
|
Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone
- RA'ANANA, Israel , Feb. 27, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, announced today that the Company President, Director and co-founder, Mr.
- 02/27/2024
|
Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements
- RA'ANANA, Israel , Feb. 27, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, has announced that the Company is progressing towards 510(k) clearance from the U.S. Food & Drug Administration ("FDA") for its INSPIRA™ ART100 in the first half of 2024.
- 02/27/2024
|
Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies
- RA'ANANA, Israel , Feb. 22, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company targeting to supersede mechanical ventilators, has unveiled an exclusive in-house capability designed to simulate both the arterial and venous blood parameters of patients with specific medical conditions without the need of in vivo animal testing.
- 02/22/2024
|
Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
- 94% of the Claims Were Found to be Novel RA'ANANA, Israel , Feb. 14, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), is a breakthrough medical technology company targeting to supersede mechanical ventilators, has received the first ever U.S. Patent approval for an orbiting blood oxygenation delivery system, a core technology of the revolutionary INSPIRA™ ART500 device.
- 02/14/2024
|
Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device
- T h e parties have entered a non-binding Letter of Intent RA'ANANA, Israel , Feb. 8, 2024 /PRNewswire/ -- Inspira Technologies OXY BHN Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, has announced the signing of a non-binding Letter of Intent (LOI) with Shamir Medical Center (Assaf Harofeh), a renowned healthcare institution in central Israel.
- 02/08/2024
|
Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices
- The agreement to potentially provide Inspira Technologies with $32.6 million over a 5-year period, subject to regulatory approvals RA'ANANA, Israel , Jan. 30, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, today announced its summary distribution agreement (the "Agreement") with Glo-Med Networks, Inc. ("Glo-Med"), a U.S. company with a regional office in Jeddah, Saudi Arabia.
- 01/30/2024
|
Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity
- The kit is being designed for the INSPIRA™ ART device series and is intended to be compatible with various life support machines sold in the market RA'ANANA, Israel, Jan. 9, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, today announced its plan to launch a single-use disposable blood oxygenation kit (the "Kit"), currently in development, for its INSPIRA ART medical device series.
- 01/09/2024
|
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
- RA'ANANA, Israel , Jan. 2, 2024 /PRNewswire/ -- Inspira Technologies OXY B . H . N Ltd.
- 01/02/2024
|
Inspira (IINN) Expands in Life Support Space With New Deal
- According to Inspira (IINN), the integration of its technology to oxygenate blood combined with Ennocure's infection prevention solutions is likely to help improve patient outcomes in ICUs.
- 11/30/2023
|
Inspira (IINN) Advances Foothold in Europe With Extended Deal
- The extended service agreement complements a previously announced strategic agreement between Inspira (IINN) and Innovimed.
- 08/31/2023
|
Inspira(TM) Technologies to Present at the Planet MicroCap Showcase 2023 on Wednesday, April 26, 2023 in Las Vegas
- RA'ANANA, ISRAEL / ACCESSWIRE / April 24, 2023 / Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN)(NASDAQ:IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care, has announced today that Joe Hayon, President and Co-Founder of Inspira Technologies, will present at the 2023 Planet MicroCap Showcase in Las Vegas this week on Wednesday at 14:30 CST, April 26, 2023.
- 04/24/2023
|
Why Inspira Technologies Stock Soared Today
- Inspira Technologies Oxy BHN Ltd (NASDAQ: IINN) shares closed up76.6% at $2.19 Wednesday after the company announced it developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition. Inspira's blood sensor, HYLA, is.
- 07/06/2022
|
Why Is Inspira Technologies (IINN) Stock Up 100% Today?
- As Inspira Technologies advances a new blood sensor with the potential to change patient outcomes, IINN stock is quickly heading north. The post Why Is Inspira Technologies (IINN) Stock Up 100% Today?
- 07/06/2022
|
3 Hot Penny Stocks to Watch Under $4 Right Now
- Here are three penny stocks to check out today The post 3 Hot Penny Stocks to Watch Under $4 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 02/02/2022
|
5 Short Squeeze Penny Stocks To Buy For Under $5 Right Now
- Short interest stocks for your penny stocks watch list this week. The post 5 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 01/31/2022
|
5 Top Penny Stocks To Buy Under $5 Right Now
- Penny stocks to buy for under $5. The post 5 Top Penny Stocks To Buy Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 01/28/2022
|
IINN Stock Alert: Is a Big Short Squeeze Brewing for Inspira Technologies?
- IINN stock is in the spotlight on the last trading day of the year, as bulls look for Inspira to enjoy one last potential short squeeze. The post IINN Stock Alert: Is a Big Short Squeeze Brewing for Inspira Technologies?
- 12/31/2021
|
Most Active Penny Stocks To Watch Before 2022
- Most active penny stocks to watch right now. The post Most Active Penny Stocks To Watch Before 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 12/30/2021
|
3 Trending Penny Stocks to Add to Your Watchlist Right Now
- Add these penny stocks to your trending small-caps watchlist The post 3 Trending Penny Stocks to Add to Your Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 12/27/2021
|
5 Short Squeeze Candidates To Watch: Biofrontera Rejoins And Tops List, 2 New Names Enter Leaderboard
- Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile examples of short squeezes earlier this year.
- 12/27/2021
|
4 Penny Stocks Analysts Say To Buy Now & Targets Up To 117%
- 4 penny stocks with bullish price targets & buy ratings from analysts. The post 4 Penny Stocks Analysts Say To Buy Now & Targets Up To 117% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 12/22/2021
|
Best Penny Stocks To Buy? 5 Short Squeeze Stocks To Watch Right Now
- 5 penny stocks with high short interest to add to your watch list in December. The post Best Penny Stocks To Buy?
- 12/21/2021
|
Inspira Technologies Oxy Stock (IINN): Why The Price Is Skyrocketing Today
- The stock price of Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) increased by over 131% during intraday trading today.
- 12/09/2021
|
IINN Stock Alert: Why Investors Are Buzzing About Inspira Technologies as Shares Blast Higher
- Inspira Technologies (IINN) stock is rocketing higher on Thursday after signing a distribution deal with Innovimed for its ART device. The post IINN Stock Alert: Why Investors Are Buzzing About Inspira Technologies as Shares Blast Higher appeared first on InvestorPlace.
- 12/09/2021
|
5 Reddit Penny Stocks To Watch This Week
- Penny stocks gaining interest on Reddit to add to your watch list this week. The post 5 Reddit Penny Stocks To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 11/28/2021
|
Inspira Technologies Oxy (IINN) Stock: Why The Price Jumped Today
- The stock price of Inspira Technologies Oxy BHN Ltd (NASDAQ: IINN) increased by over 25% pre-market today. This is why it happened.
- 11/24/2021
|
Best Penny Stocks To Buy Now? 7 Hot Reddit Stocks To Watch
- Reddit penny stocks to watch today. The post Best Penny Stocks To Buy Now?
- 11/09/2021
|
Why Did Inspira Technologies Stock Quadruple Today?
- Inspira Technologies OXY BHN Ltd (NASDAQ:IINN) has signed an exclusive distribution agreement with Anita Técnica S.L. (WAAS Group).
- 10/26/2021
|
Aegis Capital Corp. acted as Sole Bookrunner on a $16.0 Million Initial Public Offering of Common Units for Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW)
- NEW YORK, NY / ACCESSWIRE / July 19, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $16.0 Million Initial Public Offering of Common Units for Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN, IINNW) About Inspira Technologies OXY B.H.N.
- 07/19/2021
|
Inspira Technologies OXY B.H.N. Ltd Announces Closing of Initial Public Offering
- RA'ANANA, Israel, July 16, 2021 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd (the "Company"), a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology, today announced the closing of its initial public offering of 2,909,091 units at a public offering price of $5.51 per unit, each consisting of one ordinary share and one warrant to purchase one ordinary share, with an initial exercise price of $5.50 per share.
- 07/16/2021
|
